Literature DB >> 18097638

Zinc transporter mRNA expression in the RWPE-1 human prostate epithelial cell line.

Amy L Albrecht1, Seema Somji, Mary Ann Sens, Donald A Sens, Scott H Garrett.   

Abstract

The human prostate gland undergoes a prominent alteration in Zn+2 homeostasis during the development of prostate cancer. The goal of the present study was to determine if the immortalized human prostate cell line (RWPE-1) could serve as a model system to study the role of zinc in prostate cancer. The study examined the expression of mRNA for 19 members of the zinc transporter gene family in normal prostate tissue, the prostate RWPE-1 cell line, and the LNCaP, DU-145 and PC-3 prostate cancer cell lines. The study demonstrated that the expression of the 19 zinc transporters was similar between the RWPE-1 cell line and the in situ prostate gland. Of the 19 zinc transporters, only 5 had levels that were different between the RWPE-1 cells and the tissue samples; all five being increased (ZnT-6, Zip-1, Zip-3A, Zip-10, and Zip-14). The response of the 19 transporters was also determined when the cell lines were exposed to 75 microM Zn+2 for 24 h. It was shown for the RWPE-1 cells that only 5 transporters responded to Zn+2 with mRNA for ZnT-1 and ZnT-2 being increased while mRNA for ZnT-7, Zip-7 and Zip-10 transporters were decreased. It was shown for the LNCaP, DU-145 and PC-3 cells that Zn+2 had no effect on the mRNA levels of all 19 transporters except for an induction of ZnT-1 in PC-3 cells. Overall, the study suggests that the RWPE-1 cells could be a valuable model for the study of the zinc transporter gene family in the prostate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18097638     DOI: 10.1007/s10534-007-9129-0

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  8 in total

1.  miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells.

Authors:  Brittany L Mihelich; Ekaterina A Khramtsova; Nicole Arva; Avani Vaishnav; Daniel N Johnson; Angeline A Giangreco; Elena Martens-Uzunova; Omar Bagasra; André Kajdacsy-Balla; Larisa Nonn
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

2.  Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway.

Authors:  Konstantin Golovine; Robert G Uzzo; Peter Makhov; Paul L Crispen; David Kunkle; Vladimir M Kolenko
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

Review 3.  Zinc transporters in prostate cancer.

Authors:  M-C Franz; P Anderle; M Bürzle; Y Suzuki; M R Freeman; M A Hediger; G Kovacs
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

4.  Zinc, Zinc Transporters, and Cadmium Cytotoxicity in a Cell Culture Model of Human Urothelium.

Authors:  Soisungwan Satarug; Scott H Garrett; Seema Somji; Mary Ann Sens; Donald A Sens
Journal:  Toxics       Date:  2021-04-24

Review 5.  Zinc in innate and adaptive tumor immunity.

Authors:  Erica John; Thomas C Laskow; William J Buchser; Bruce R Pitt; Per H Basse; Lisa H Butterfield; Pawel Kalinski; Michael T Lotze
Journal:  J Transl Med       Date:  2010-11-18       Impact factor: 5.531

Review 6.  The Role of Zinc and Copper in Gynecological Malignancies.

Authors:  Kaja Michalczyk; Aneta Cymbaluk-Płoska
Journal:  Nutrients       Date:  2020-12-03       Impact factor: 5.717

7.  Methaneseleninic acid and γ-Tocopherol combination inhibits prostate tumor growth in Vivo in a xenograft mouse model.

Authors:  Chandra K Singh; Mary A Ndiaye; Imtiaz A Siddiqui; Minakshi Nihal; Thomas Havighurst; KyungMann Kim; Weixiong Zhong; Hasan Mukhtar; Nihal Ahmad
Journal:  Oncotarget       Date:  2014-06-15

8.  The emerging role of zinc transporters in cellular homeostasis and cancer.

Authors:  Elizabeth Bafaro; Yuting Liu; Yan Xu; Robert E Dempski
Journal:  Signal Transduct Target Ther       Date:  2017-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.